Terms: = Thyroid cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
5132 results:
1. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
2. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
[TBL] [Abstract] [Full Text] [Related]
3. Score based on contrast-enhanced ultrasound predict central lymph node metastasis in papillary thyroid cancer.
He L; Chen X; Hu J; Meng Y; Zhang Y; Chen W; Fan Y; Li T; Fang J
Front Endocrinol (Lausanne); 2024; 15():1336787. PubMed ID: 38699389
[TBL] [Abstract] [Full Text] [Related]
4. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
5. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
7. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
[TBL] [Abstract] [Full Text] [Related]
8. PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y; Koyama T; Matsubara N; Naito Y; Kondo S; Harano K; Yonemori K; Yoh K; Gu Y; Mita T; Chen X; Ueda E; Yamamoto N; Doi T; Shimizu T
Cancer Med; 2024 Apr; 13(8):e6980. PubMed ID: 38651187
[TBL] [Abstract] [Full Text] [Related]
9. Human papillomavirus and Epstein-Barr virus infection in benign thyroid lesions.
Lu Y; Zhao R; Zhang Y; Huang S; Chen X
Endokrynol Pol; 2024; 75(2):179-182. PubMed ID: 38646990
[TBL] [Abstract] [Full Text] [Related]
10. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence and impact of endocrine disorders in advanced metastatic cancer patients undergoing cancer-directed therapy: A prospective observational study.
Karna G; Sehrawat A; Karna S; Kant R; Sundriyal D; Karn S; Jha D
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2011. PubMed ID: 38644759
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Follow-up of Patients With Autonomous thyroid Nodules Treated With Radioiodine.
Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
[TBL] [Abstract] [Full Text] [Related]
13. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of ultrasound-guided microwave ablation, laser ablation, and radiofrequency ablation for the treatment of elderly patients with benign thyroid nodules: A meta-analysis.
Qian Y; Li Z; Fan C; Huang Y
Exp Gerontol; 2024 Jun; 191():112425. PubMed ID: 38604254
[TBL] [Abstract] [Full Text] [Related]
15. Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study.
Christensen SK; Winther ML; Laursen IJ; Madsen FS; Brink C; Brix TH; Ellebaek E; Svane IM; Hansen FS; Haslund C; Laursen OK; Schmidt H; Larsen ID; Bastholt L; Ruhlmann CH
Support Care Cancer; 2024 Apr; 32(5):281. PubMed ID: 38598052
[TBL] [Abstract] [Full Text] [Related]
16. Factors associated with non-completion of palliative radiotherapy for spinal metastasis in patients with terminal cancer: a retrospective study.
Tokiya R; Nakanishi K; Okawaki M; Yamamoto A; Yamamoto Y; Saisho S; Fukuda Y; Nishie H; Teramoto S; Miyaji Y
Ann Palliat Med; 2024 Mar; 13(2):249-259. PubMed ID: 38584473
[TBL] [Abstract] [Full Text] [Related]
17. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
18. Contents analysis of thyroid cancer-related information uploaded to YouTube by physicians in Korea: endorsing thyroid cancer screening, potentially leading to overdiagnosis.
Kang E; Ju H; Kim S; Choi J
BMC Public Health; 2024 Apr; 24(1):942. PubMed ID: 38566004
[TBL] [Abstract] [Full Text] [Related]
19. Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
Lee-Saxton YJ; Palacardo F; Greenberg JA; Egan CE; Marshall TE; Tumati A; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
Surgery; 2024 Jan; 175(1):215-220. PubMed ID: 38563429
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
[Next]
